gp100-Reactive Autologous Tumor Infiltrating Lymphocyte
Tumor infiltrating lymphocytes (TIL) isolated from a patient, exposed to the tumor-associated antigen gp100 in vitro, and then transferred back to the same patient to target tumor cells expressing gp100. gp100 human antigen is a wild-type self-antigen expressed by melanocytes, pigmented retinal cells and most melanomas. (NCI04) [ ]
Term info
gp100-Reactive Autologous Tumor Infiltrating Lymphocyte
- gp100-Reactive Autologous TIL
- gp100-Reactive Autologous Tumor Infiltrating Lymphocyte
http://purl.obolibrary.org/obo/NCIT_C2386
gp100-Reactive_Autologous_Tumor_Infiltrating_Lymphocyte
731217
gp100-Reactive Autologous Tumor Infiltrating Lymphocyte
Pharmacologic Substance, Cell
C1515627
C38125
Term relations
- Therapeutic Tumor Infiltrating Lymphocytes
- Chemical_Or_Drug_Has_Physiologic_Effect some T-Cell Activation
- Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some Cytotoxic T-Lymphocyte
- Chemical_Or_Drug_Has_Mechanism_Of_Action some Antigen Sensitization
- Chemical_Or_Drug_Has_Physiologic_Effect some Immunopotentiation